5PSQ-033 High dosage of tigecycline in multidrug-resistant acinetobacter baumannii: use analysis during an outbreak

BACKGROUND: Acinetobacter baumannii has become an important hospital-acquired pathogen. With the rise in antibiotic resistance, tigecycline has been used frequently against multidrug-resistant acinetobacter baumannii (MRAB). PURPOSE: To analyse the use of tigecycline after an outbreak of MRAB in a t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur J Hosp Pharm
Autors principals: Requejo, C Caballero, Candel, M Gil, Muñoz, C Gallego, Candela, M Onteniente, Valverde, I Salar, Sanz, E Urbieta
Format: Artigo
Idioma:Inglês
Publicat: BMJ Group 2018
Matèries:
Section 5: Patient safety and quality assurance
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535495/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.387
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars